Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance Study.
Afif W, Arasaradnam RP, Abreu MT, Danese S, Sandborn WJ, Miao Y, Zhang H, Panaccione R, Hisamatsu T, Scherl EJ, Leong RW, Rowbotham DS, Peyrin-Biroulet L, Sands BE, Marano C. Afif W, et al. Am J Gastroenterol. 2024 May 1;119(5):910-921. doi: 10.14309/ajg.0000000000002621. Epub 2023 Dec 14. Am J Gastroenterol. 2024. PMID: 38095692 Free PMC article. Clinical Trial.
Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study.
Wetwittayakhlang P, Golovics PA, Khoury AA, Ganni E, Hahn GD, Cohen A, Wyse J, Bradette M, Bessissow T, Afif W, Wild G, Bitton A, Lakatos PL. Wetwittayakhlang P, et al. Among authors: afif w. J Gastrointestin Liver Dis. 2022 Dec 16;31(4):403-410. doi: 10.15403/jgld-4375. J Gastrointestin Liver Dis. 2022. PMID: 36535055 Free article.
Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study.
Wetwittayakhlang P, Verdon C, Starr M, Hahn GD, Golovics PA, Bessissow T, Afif W, Wild G, Bitton A, Lakatos PL. Wetwittayakhlang P, et al. Among authors: afif w. Turk J Gastroenterol. 2023 Jun;34(6):603-610. doi: 10.5152/tjg.2023.22527. Turk J Gastroenterol. 2023. PMID: 37162506 Free PMC article.
Serious Infections in Offspring Exposed in Utero to Vedolizumab.
Gorodensky JH, Bernatsky S, Afif W, St-Pierre Y, Filion KB, Vinet É. Gorodensky JH, et al. Among authors: afif w. Inflamm Bowel Dis. 2024 Mar 1;30(3):496-498. doi: 10.1093/ibd/izad079. Inflamm Bowel Dis. 2024. PMID: 37172205 Free PMC article.
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease.
Khanna R, Sattin BD, Afif W, Benchimol EI, Bernard EJ, Bitton A, Bressler B, Fedorak RN, Ghosh S, Greenberg GR, Marshall JK, Panaccione R, Seidman EG, Silverberg MS, Steinhart AH, Sy R, Van Assche G, Walters TD, Sandborn WJ, Feagan BG. Khanna R, et al. Among authors: afif w. Aliment Pharmacol Ther. 2013 Sep;38(5):447-59. doi: 10.1111/apt.12407. Epub 2013 Jul 14. Aliment Pharmacol Ther. 2013. PMID: 23848220 Free article. Review.
116 results